Pre-conference Symposium for Managed Care and Specialty Pharmacy Professionals
1:45 PM - 5:00 PM
Gaylord Palms Resort & Convention Center
Room: Sun A
Orlando, FL
- Strategies used by managed care organizations (MCOs) and specialty pharmacy providers to facilitate high quality care
- Impact of updated clinical recommendations for hemophilia, including prophylactic factor replacement and the role of emerging agents
- Hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
- Opportunities to improve communications with HTCs
- Methods for optimal cost management of factor replacement therapy
| Moderator | |||
|
Jeffrey Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx Pharmacy Services, LLC |
||
| Faculty | |||
|
Amber Federizo, APRN, FNP-BC Nurse Practitioner Hemophilia Treatment Center of Nevada |
|
James Kenney, Jr., RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care |
|
Jonathan C. Roberts, MD Associate Medical Director Bleeding & Clotting Disorders Institute Assistant Professor of Pediatrics University of Illinois College of Medicine at Peoria |
||
This activity is designed to meet the educational needs of managed care and specialty pharmacy professionals, medical directors, pharmacy directors, and other health care professionals with an interest in the management of patients with hemophilia.
Upon completing this activity, the participant should be better able to:
- Describe current and evolving strategies used by managed care organizations (MCOs) and specialty pharmacy providers to facilitate high quality care for members with hemophilia
- Cite the most recent clinical recommendations for the treatment of patients with hemophilia, including prophylactic factor replacement and the role of emerging agents
- Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
- Employ processes for MCOs and specialty pharmacy providers to improve communications with HTCs
- Apply methods to enable optimal cost management of factor replacement therapy to be realized by multiple hemophilia stakeholders including MCOs and specialty pharmacy providers
Date and Time
Thursday, July 21, 2016
1:45 PM - 5:00 PM
Gaylord Palms Resort & Convention Center
Room: Sun A
Orlando, FL
| 1:45 PM |
Registration and Refreshments |
| 2:00 PM |
Opening Comments and Pre-activity Assessment
Jeffrey Dunn, PharmD, MBA |
| 2:05 PM |
Medical Management Strategies to Integrate Hemophilia Care with Payer Policies
Jeffrey Dunn, PharmD, MBA |
| 2:30 PM |
Managing Patients with Inhibitors: Coordinated Care for Optimal Outcomes
Jonathan Roberts, MD |
| 3:00 PM |
Moderated Faculty Panel Discussion Entire Faculty Panel |
| 3:15 PM |
Recommendations to Streamline the Pre-Certification and Prior Authorization Process Amber Federizo, APRN, FNP-BC |
| 4:00 PM |
HTC and Specialty Pharmacy Collaboration: Steps for Success James Kenney, Jr., RPh, MBA |
| 4:30 PM |
Moderated Faculty Panel Discussion and Audience Q&A
Entire Faculty Panel |
| 4:55 PM |
Closing Comments Post-activity Assessment and Evaluations |
| 5:00 PM | Adjournment |
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, the National Hemophilia Foundation, and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
 |
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 3.0 contact hours (0.30 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - (0809-9999-16-278-L01-P)
Type of Activity: Knowledge
For Pharmacists: Upon receipt of a completed activity evaluation form, ACPE credit will be uploaded to the CPE Monitor. Log into your NAPB account within 4-6 weeks of the activity date to ensure your credit has posted.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Note: There is NO FEE for attending this session. However, if you wish to attend the NHF Annual Meeting sessions from July 21-July 23, 2016, a registration fee is required.
Pre-registration will close at 12:00 pm on July 20, 2016.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.